Sugi Predict

Sugi Predict / Compounds / SCHEMBL9010601

SCHEMBL9010601

SCHEMBL9010601

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ LNPEP Q9UIQ6 5/20 0.64
▸ ANPEP P15144 3/20 0.64
▸ NTSR2 O95665 12/20 0.60
▸ NTSR1 P30989 12/20 0.60
▸ SORT1 Q99523 11/20 0.59
▸ REN P00797 1/20 0.57
▸ AGTR1 P30556 1/20 0.56
▸ AGTR2 P50052 1/20 0.56
▸ F2 P00734 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9010597 1.00 LNPEP (0.64) LNPEPANPEPNTSR2NTSR1SORT1
Angiotensin Iv SCHEMBL4322224 0.96 LNPEP (0.68) LNPEPANPEPNTSR2NTSR1SORT1
Angiotensin Iv SCHEMBL4322236 0.96 LNPEP (0.68) LNPEPANPEPNTSR2NTSR1SORT1
SCHEMBL29568673 0.93 NTSR1 (0.61) LNPEPANPEPNTSR2NTSR1SORT1
SCHEMBL29568971 0.92 REN (0.60) LNPEPANPEPNTSR2NTSR1REN
SCHEMBL11204440 0.91 LNPEP (0.60) LNPEPANPEPNTSR2NTSR1SORT1
SCHEMBL11204436 0.91 LNPEP (0.60) LNPEPANPEPNTSR2NTSR1SORT1
SCHEMBL29619755 0.91 LNPEP (0.63) LNPEPANPEPRENAGTR1AGTR2
SCHEMBL4757113 0.91 LNPEP (0.57) LNPEPANPEPNTSR2NTSR1SORT1
SCHEMBL4756905 0.91 LNPEP (0.59) LNPEPANPEPNTSR2NTSR1REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441990-B2 Host cell including expression vector for encoding catalysis deactivated angiotensin-converting enzyme 2 (ACE2) variants AVIRMAX, INC. (US) 2025-10-14 — — US disclosed
US-20240218343-A1 Catalysis deactivated angiotensin-converting enzyme 2 (ACE2) variants and their uses AVIRMAX INC (US) 2024-07-04 — — US disclosed
EP-4090965-A1 LOW BINDING SURFACES FOR PEPTIDE MAPPING Waters Technologies Corporation (US) 2022-11-23 — — EP disclosed
EP-0740790-A1 HOMOGENEOUS IMMUNOASSAYS AND ENZYME BASED ASSAYS OF ANALYTES USING CAPILLARY ELECTROPHORESIS BECKMAN INSTRUMENTS, INC. (US) 1996-11-06 — — EP disclosed
WO-1995020161-A1 HOMOGENEOUS IMMUNOASSAYS AND ENZYME BASED ASSAYS OF ANALYTES USING CAPILLARY ELECTROPHORESIS BECKMAN INSTRUMENTS, INC. (US) 1995-07-27 — — WO disclosed